Publications by authors named "Hadeel Samarkandi"

Claim this Profile
R
Ramadan fasting and hematological disorders: clinical considerations, risks, and management strategies.
Abdulrahman Nasiri, Ahmed Alahmadi, Manal Alshammari, Ruba Alabiri, Sara Samarkandi, Hadeel Samarkandi

Clin Hematol Int· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Setting up a Chimeric Antigen Receptor T Cell Therapy Program: A Framework for Delivery from the Worldwide Network for Blood & Marrow Transplantation.
Syed Osman Ahmed, Riad El Fakih, Mohamed A Kharfan-Dabaja, Farhatullah Syed, Ghulam Mufti, Hadeel Samarkandi

Transplant Cell Ther· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Haplo-stem cell transplant post liver transplantation to cure sickle cell disease with related liver dysfunction: a case series.
Ali D Alahmari, Saad Alghamdi, Reem Alasbali, Sara Hisham Samarkandi, Saleh A Alqahtani, Hadeel Samarkandi

Commun Med (Lond)· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Author Correction: Haplo-stem cell transplant post liver transplantation to cure sickle cell disease with related liver dysfunction: a case series.
Ali D Alahmari, Saad Alghamdi, Reem Alasbali, Sara Hisham Samarkandi, Saleh A Alqahtani, Hadeel Samarkandi

Commun Med (Lond)· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Revisiting intrathecal thiotepa: Efficacy and safety in secondary CNS malignancies.
Trevor Jamison, Emaan Haque, Ibrahim N Muhsen, Hadeel Samarkandi, Riad El Fakih

Med Oncol· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Role of Anti-CD38 Monoclonal Antibodies in the Treatment of Adult Immune Hematological Diseases.
Erin H Yang, Ibrahim N Muhsen, Hadeel Samarkandi, Riad El Fakih, Mahmoud Aljurf

Hematol Oncol Stem Cell Ther· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Full Dose Cyclophosphamide with the Addition of Fludarabine for Matched Sibling Transplants in Severe Aplastic Anemia.
Riad El Fakih, Saud Alhayli, Syed Osman Ahmed, Marwan Shaheen, Naeem Chaudhri, Hadeel Samarkandi

Transplant Cell Ther· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cardiovascular Toxicity Associated With Tyrosine Kinase Inhibitor Therapy In Chronic Myeloid Leukemia.
Abdulaziz A Binzaid, Omar J Baqal, Mohammed Soheib, Mohammad Al Nahedh, Hadeel H Samarkandi

Gulf J Oncolog· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cancer Management in Saudi Arabia: Recommendations by the Saudi Oncology HeAlth Economics ExpeRt GrouP (SHARP).
Nora Alkhudair, Majed Alshamrani, Hadeel Samarkandi, Hajer Almodaheem, Hana Alabdulkarim

Saudi Pharm J· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bortezomib for immune thrombocytopenia and autoimmune hemolytic anemia.
Ibrahim N Muhsen, Ali Alahmari, Mohammed Alnahedh, Nora A Alkhudair, Hadeel Samarkandi

Hematol Oncol Stem Cell Ther· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Practical strategies to manage cancer patients during the COVID-19 pandemic: Saudi Oncology Pharmacy Assembly Experts recommendations.
Majed Alshamrani, Atika AlHarbi, Nora Alkhudair, Fouad AlNajjar, Mansoor Khan, Hadeel Samarkandi

J Oncol Pharm Pract· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis